We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neuropsychomotor Functions in Children With Autism Spectrum Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01987037
Recruitment Status : Unknown
Verified July 2015 by Bertrand Olliac, Centre Hospitalier Esquirol.
Recruitment status was:  Recruiting
First Posted : November 19, 2013
Last Update Posted : August 3, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The aim of the study is to describe the feasibility of the passation of the assessment battery of psychomotor functions tests (NP-MOT) in children aged 4 to 11 years with a diagnosis of autism spectrum disorder: number and type of evaluable events, number and type of tests with a deficit compared to the standard results.

Condition or disease Intervention/treatment
Autism Spectrum Disorder Behavioral: neuropsychomotor assessment

Detailed Description:

After informed consent obtention, the children will be submitted to the different tests of the battery to evaluate the psychomotor functions. The results will be compared with other data collected from the routine practise : socio-demographic data, medical and developmental antecedents,psychological tests (KABC II, Rey test, London Tower test, ...), psychomotor evaluation (MABC, evaluation of manual praxis, visual abilities, Frostig test), understanding data (N-EEL test), neuropediatric examination, clinical assessment (ADI-R, CARS).

The use of this battery allows this fine discriminative assessment of the psychomotor functions involved in the movement. Exploring each function will allow to take into account qualitative and quantitative aspects of the movement in every aspects, and this is not applied in the routine care until now. Calibration for each event can explore each function independently of each other, and will provide information to determine any specific developmental characteristics improve care.


Study Design

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Neuropsychomotor Functions in Children With Autism Spectrum Disorder
Study Start Date : October 2013
Estimated Primary Completion Date : February 2016
Estimated Study Completion Date : February 2016

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
tests evaluation
children with autism spectrum disorder subjected to the NP-MOT tests
Behavioral: neuropsychomotor assessment
Children with autism spectrum disorders pass a specific battery test (NP-MOT) for a neuropsychomotor assessment. This neuropsychomotor assessment is administered in a half-day maximum. This battery aims to investigate passive muscle tone (shoulders, limbs, and trunk), standing and synkinesia, static and dynamic balance, tonic laterality (extensibility and dangling of hands and feet to identify the tonic dominant side), laterality of use, fine-digit movements, digital tactile gnosis, and body spatial integration (knowing left from right: for oneself and that of others, and with regard to objects).


Outcome Measures

Primary Outcome Measures :
  1. results to the NP-MOT tests battery [ Time Frame: one day ]

    the NP-MOT battery tests include several tests to evaluate 9 motor functions (muscle tone, gross motor, laterality, fine-digit movement, digital tactile gnosis, hand-eye skill, body spatial orientation, pace, auditory attention) with 48 subtests.

    We describe:

    number and type of evaluable tests, number and type of tests with results with 1 Standard Deviation different from the standard results.

    number and type of tests with results with 2 Standard Deviation different from the standard results.



Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Years to 11 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
children attended in the Centre Hospitalier Esquirol and the CRA (Autism Reference Center) in Limousin, France, for suspiscion of autism
Criteria

Inclusion Criteria:

  • informed consent from the parents or the legal representative
  • age 4 to 11
  • autism spectrum disorder diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition- text revised

Exclusion Criteria:

  • bad understanding of the french language
  • motor disability from lesion or accidental origin, proved genetic or neurologic disease
  • deafness, blindness
  • parents with administrative or judiciary protection, and without health insurance
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01987037


Contacts
Contact: Aude Paquet 0033555431010 ext 3185 audepaquet@gmail.com
Contact: Murielle Girard, PhD 0033555431028 murielle.girard@ch-esquirol-limoges.fr

Locations
France
Centre de Ressources Autisme Limousin Recruiting
Limoges, France
Centre Hospitalier esquirol Recruiting
Limoges, France
Contact: Aude Paquet    0033555431010 ext 3185    audepaquet@gmail.com   
Sponsors and Collaborators
Centre Hospitalier Esquirol
More Information

Publications:
Responsible Party: Bertrand Olliac, M.D Ph.D., Centre Hospitalier Esquirol
ClinicalTrials.gov Identifier: NCT01987037     History of Changes
Other Study ID Numbers: 2013-A00644-41
First Posted: November 19, 2013    Key Record Dates
Last Update Posted: August 3, 2015
Last Verified: July 2015

Keywords provided by Bertrand Olliac, Centre Hospitalier Esquirol:
autism spectrum disorder
neuropsychomotor assessment
NP-MOT
motor skills
gross motor

Additional relevant MeSH terms:
Disease
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Pathologic Processes
Neurodevelopmental Disorders
Mental Disorders